Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 6, 2015, 67 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $228.16 to $2,641,920.00.

Highlighted Stocks Traded by Insiders:

Tesco (TESO) - FREE Research Report

Quintana Julio M, who is Director at Tesco, sold 21,507 shares at $12.12 on Jan. 6, 2015. Following this transaction, the Director owned 263,568 shares meaning that the stake was reduced by 7.54% with the 21,507-share transaction.

Assing Fernando Rafael, who is President & CEO at Tesco, sold 5,329 shares at $12.35 on Jan. 6, 2015. Following this transaction, the President & CEO owned 56,095 shares meaning that the stake was reduced by 8.68% with the 5,329-share transaction.

Ferris Mihial Dean, who is SVP, Gen Counsel & Corp Sec at Tesco, sold 2,812 shares at $12.21 on Jan. 6, 2015. Following this transaction, the SVP, Gen Counsel & Corp Sec owned 11,372 shares meaning that the stake was reduced by 19.83% with the 2,812-share transaction.

The shares most recently traded at $11.69, down $0.52, or 4.48% since the insider transaction. Historical insider transactions for Tesco go as follows:

  • 4-Week # shares sold: 3,000
  • 12-Week # shares sold: 18,599
  • 24-Week # shares sold: 22,023

The average volume for Tesco has been 369,700 shares per day over the past 30 days. Tesco has a market cap of $483.2 million and is part of the basic materials sector and energy industry. Shares are down 8.58% year-to-date as of the close of trading on Tuesday.

Tesco Corporation, together with its subsidiaries, is engaged in the design, manufacture, and service delivery of technology-based solutions for the upstream energy industry worldwide. The company operates through Top Drive and Tubular Services segments. The stock currently has a dividend yield of 1.64%. The company has a P/E ratio of 17.4. Currently, there are 5 analysts who rate Tesco a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on TESO - FREE

TheStreet Quant Ratings

rates Tesco as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Tesco Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Alimera (ALIM) - FREE Research Report

Myers C. Daniel, who is President and CEO at Alimera, sold 2,000 shares at $5.51 on Jan. 6, 2015. Following this transaction, the President and CEO owned 102,817 shares meaning that the stake was reduced by 1.91% with the 2,000-share transaction.

Historical insider transactions for Alimera go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 61,918
  • 24-Week # shares sold: 115,634

The average volume for Alimera has been 297,100 shares per day over the past 30 days. Alimera has a market cap of $252.9 million and is part of the health care sector and drugs industry. Shares are down 0.36% year-to-date as of the close of trading on Tuesday.

Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. The company focuses on diseases affecting the back of the eye or retina. Currently, there is 1 analyst who rates Alimera a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALIM - FREE

TheStreet Quant Ratings

rates Alimera as a

sell

. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally high debt management risk and feeble growth in its earnings per share. Get the full

Alimera Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Nuance Communications (NUAN) - FREE Research Report

Bowden Adam Bruce, who is Executive VP Corporate Strateg at Nuance Communications, sold 1,500 shares at $14.26 on Jan. 6, 2015. Following this transaction, the Executive VP Corporate Strateg owned 293,190 shares meaning that the stake was reduced by 0.51% with the 1,500-share transaction.

The shares most recently traded at $13.80, down $0.46, or 3.32% since the insider transaction. Historical insider transactions for Nuance Communications go as follows:

  • 4-Week # shares bought: 11,657
  • 4-Week # shares sold: 8,500
  • 12-Week # shares bought: 11,657
  • 12-Week # shares sold: 17,000
  • 24-Week # shares bought: 11,657
  • 24-Week # shares sold: 54,875

The average volume for Nuance Communications has been 2.1 million shares per day over the past 30 days. Nuance Communications has a market cap of $4.5 billion and is part of the technology sector and computer software & services industry. Shares are down 2.87% year-to-date as of the close of trading on Tuesday.

Nuance Communications, Inc. provides voice and language solutions for businesses and consumers worldwide. Currently, there are 2 analysts who rate Nuance Communications a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NUAN - FREE

TheStreet Quant Ratings

rates Nuance Communications as a

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself. Get the full

Nuance Communications Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null